Article
A non-canonical glucose metabolic rewiring enables resistance to cancer targeted therapy
2024-12-20
Abstract excerpt
Targeting glucose metabolism for cancer therapy is a long-lasting pursuit but with disappointing translational success. Revelation of actionable distinctions between the malignancy traits to achieve selectivity is a prerequisite for fulfilling a therapeutic window. We discover a non-canonical glucose transporter GLUT6-facilitated, lactate-independent, glucose metabolic rewiring that selectively enables resistance...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e0ff8d6d-6abb-53b5-8b36-233147d4f1ae
- DOI
- 10.1101/2024.12.19.629335
